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INTRODUCTION
Q fever is an ubiquitous zoonosis caused by
Coxiella burnetii that may cause acute or chronic
infections [1]. Acute Q fever is asymptomatic in
60% of infected persons and in symptomatic
patients the clinical presentation is polymorphic
and non-speciﬁc. The major forms of acute Q
fever described to date are febrile illness, atypical
pneumonia and hepatitis. Acute Q fever is usually
mild but patients with cardiovascular abnormal-
ities are at risk of developing chronic infection [2].
In patients with chronic Q fever, endocarditis is
the most common feature, but vascular infections
are also observed. Q fever has been estimated to
represent 3–5% of all cases of endocarditis. The
most common method for the diagnosis of Q fever
remains serology using micro immunoﬂuores-
cence. Culture is the gold standard but sensitivity
is low and should be performed in specialised
Biosafety Laboratory 3. However, PCR has been
successfully used to detect C. burnetii DNA in
various samples, including cell cultures, biopsy
samples, blood, arthropods and serum samples
[3].
The objective of this study was to undertake a
retrospective analysis of the use of real-time PCR
with Taqman* probes during 3 years in the French
national reference centre for the diagnosis of Q
fever.
METHODS
As a reference centre for the diagnosis of rickettsial diseases,
our laboratory receives samples from France and other
countries for Q fever diagnosis. Serum, blood and biopsy
samples sent to our centre for suspicion of Q fever were
included in this study from January 2005 to December 2007.
Serology was performed using indirect immunoﬂuorescence,
the reference technique, and phase I and phase II antibodies
were detected, with methods previously described [4]. Molec-
ular detection of C. burnetii was performed using real-time
PCR with Taqman* probes in a Lightcycler apparatus (Roche
Diagnostics, Meylan, France). Two different target genes were
used in this study: the IS1111 repeated sequence and the IS30a
sequence using primers and Taqman* probes previously
described [5]. All biopsy samples were tested using molecular
methods whereas criteria were selected for serum samples.
Criteria to perform PCR on these samples were: patient with a
ﬁrst serum with either phase I IgG ‡ 800, or phase II IgG < 200
with positive phase II IgM, or a negative sera of a patient that
has seroconverted.
RESULTS
Overall, we have tested a total of 3219 samples,
corresponding to 1748 patients. Among these
patients, 145 samples were positive in 115 patients
(6.5%) (Fig. 1a,b). In 2005, 2006 and 2007, the
number of positive patients were 36 (8.5%), 55
(8%) and 24 (3%), respectively. The nature of the
positive samples during the 3 years was as
follows: 101 serum samples, 14 cardiac valve
samples, eight EDTA blood samples, 10 biopsy
samples (six prosthetic aortic valves, and four
aortic aneurysms), one cerebrospinal ﬂuid, one
placenta, two lymph nodes, one thrombus, one
liquid aspirate from the aortic wall, and six
miscellaneous (one tick sampled on a patient
with acute Q fever, one vein transplant, and four
aortic ﬁstula) (Fig. 1a). The 101 positive serum
samples corresponded to 89 patients. Among
these patients, 37 patients had acute Q fever,
and 52 patients had chronic Q fever, taking into
account serology results and clinical manifesta-
tions.
CONCLUSIONS
PCR is regularly performed in our laboratory;
over the 3-year period we obtained positive
results on 115 patients for C. burnetii. The positive
results were found in various samples, including
biopsies, and mainly in serum samples. Although
the use of molecular methods on biopsy samples
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is easy to perform and to interpret, especially
when serology is contributive for the diagnosis,
there are situations for which serology alone is
not sufﬁcient to eventually diagnose acute or
evolutive chronic Q fever. In our experience, we
only test by PCR serum samples that either are
not at the cutoff for a diagnosis of acute Q fever
[4] or for which a suspicion of evolutive chronic
form is ongoing. Real time PCR is a useful,
sensitive, speciﬁc and rapid tool for the diagnosis
of Q fever even on samples with few DNA such as
serum samples. Because serum is one of the
easiest human samples to obtain, this is a useful
sample for early diagnosis of chronic Q fever [3].
Also, when sampled early in the evolution of a
systemic disease, it is likely to contain DNA
copies of the involved pathogens. Thus, this is
also a useful sample for direct diagnosis of the
acute form of Q fever as demonstrated in this
study. The main problem is to establish a certain
diagnosis of chronic Q fever in patients with IgG
phase I titres ranging from 1:800 to 1:1600. In
these cases, our real-time PCR was a clue for
establishing an accurate diagnosis of chronic Q
fever. Sensitivity of our method was increased by
the use of both real-time PCR and repeated
sequences as targets.
In conclusion, our assay was a valuable tool for
the diagnosis of Q fever either on biopsy speci-
mens or on serum samples.
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Fig. 1. Nature of the PCR positive samples (a) and per-
centage of positive patients (b). *1 tick, 1 vein transplant
and 4 aortic ﬁstula.
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